Literature DB >> 12163793

Oxidative stress in critically ill patients with systemic inflammatory response syndrome.

José M Alonso de Vega1, Julián Díaz, Enrique Serrano, Luis F Carbonell.   

Abstract

OBJECTIVE: To evaluate whether critically ill patients with systemic inflammatory response syndrome, on admission to an intensive care unit, had more severe oxidative stress than those without this syndrome.
DESIGN: A prospective, cohort study.
SETTING: A mixed medical and surgical adult intensive care unit with 12 beds. PATIENTS: A total of 68 consecutive patients admitted to the intensive care unit.
INTERVENTIONS: Venous blood samples were routinely obtained within 24 hrs of admission.
MEASUREMENTS AND MAIN RESULTS: Patients' plasma total antioxidant capacity, the lipid peroxidation products malondialdehyde and 4-hydroxynonenal, reduced sulfhydryl groups, and nitrites/nitrates were measured by spectrophotometric technique at admission to the intensive care unit. Myeloperoxidase (enzyme-linked immunosorbent assay) and polymorphonuclear elastase (immuno-activation assay) were also measured on admission to the intensive care unit. The patients with criteria of systemic inflammatory response syndrome (n = 20) had higher Acute Physiology and Chronic health Evaluation III scores (determined by collecting the worst value within 24 hrs after admission to the intensive care unit) and plasma concentrations of lipid peroxidation products and nitrites/nitrates and lower plasma concentration of reduced sulfhydryl groups and plasma total antioxidant capacity than patients without the syndrome (n = 48). Moreover, the markers for leukocyte activation, myeloperoxidase and polymorphonuclear elastase, presented higher concentrations in the plasma of patients with systemic inflammatory response syndrome.
CONCLUSIONS: Patients admitted to the intensive care unit with criteria of systemic inflammatory response syndrome had a more severe oxidative stress than patients without this syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163793     DOI: 10.1097/00003246-200208000-00018

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  51 in total

1.  Death receptors mediate the adverse effects of febrile-range hyperthermia on the outcome of lipopolysaccharide-induced lung injury.

Authors:  Anne B Lipke; Gustavo Matute-Bello; Raquel Herrero; Venus A Wong; Stephen M Mongovin; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-22       Impact factor: 5.464

2.  Antioxidant therapy in sepsis.

Authors:  Gerd Albuszies; Uwe Bernd Brückner
Journal:  Intensive Care Med       Date:  2003-08-16       Impact factor: 17.440

3.  Rethinking antioxidants in the intensive care unit.

Authors:  Manu Jain; Navdeep S Chandel
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

4.  Antioxidant supplementation and atrial arrhythmias in critically ill trauma patients.

Authors:  Mina F Mirhoseini; Susan E Hamblin; W Paul Moore; Jonathan Pouliot; Judith M Jenkins; Wei Wang; Rameela Chandrasekhar; Bryan R Collier; Mayur B Patel
Journal:  J Surg Res       Date:  2017-10-31       Impact factor: 2.192

5.  Reconsidering critical illness as an uncharacterised acquired mitochondrial disorder.

Authors:  Helen T McKenna; Andrew J Murray
Journal:  J Intensive Care Soc       Date:  2019-12-10

Review 6.  Monitoring Severity of Multiple Organ Dysfunction Syndrome: New Technologies.

Authors:  Katri V Typpo; Hector R Wong; Stacey D Finley; Rodney C Daniels; Andrew J E Seely; Jacques Lacroix
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

7.  Whole Blood Redox Potential Correlates With Progressive Accumulation of Oxygen Debt and Acts as A Marker of Resuscitation in A Swine Hemorrhagic Shock Model.

Authors:  Rodney C Daniels; Hyesun Jun; Hakam Tiba; Brendan McCracken; Pilar Herrera-Fierro; Maryanne Collinson; Kevin R Ward
Journal:  Shock       Date:  2018-03       Impact factor: 3.454

8.  Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial.

Authors:  Daren K Heyland; Gunnar Elke; Deborah Cook; Mette M Berger; Paul E Wischmeyer; Martin Albert; John Muscedere; Gwynne Jones; Andrew G Day
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-05-05       Impact factor: 4.016

9.  Markers of Oxidative Stress and Clinical Outcome in Critically ill Septic Patients: A Preliminary Study from North India.

Authors:  Mradul Kumar Daga; Naushad Ahmad Khan; Harpreet Singh; Ankit Chhoda; Sahil Mattoo; Basant Kumar Gupta
Journal:  J Clin Diagn Res       Date:  2016-08-01

10.  Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients.

Authors:  Concepción F Estívariz; Daniel P Griffith; Menghua Luo; Elaina E Szeszycki; Niloofar Bazargan; Nisha Dave; Nicole M Daignault; Glen F Bergman; Therese McNally; Cindy H Battey; Celeste E Furr; Li Hao; James G Ramsay; Carolyn R Accardi; George A Cotsonis; Dean P Jones; John R Galloway; Thomas R Ziegler
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008-06-09       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.